How is the needle moving on this healthcare Stock:BioDelivery Sciences International, Inc.(NASDAQ: BDSI)

ByMarketFacts

BioDelivery Sciences International Inc (NASDAQ: BDSI) is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

Highlights:

Dec. 20, 2021, Company announced that the U.S. District Court of Delaware has issued an opinion in favor of BDSI in the company’s patent litigation against Alvogen Group, Inc. and its affiliates, who filed an Abbreviated New Drug Application (ANDA) for BDSI’s BELBUCA® product.

Recent Acquisition – Closed acquisition of ELYXYB on September 9, 2021, the first FDA-approved, ready-to-use oral solution for acute migraine with potential long-term peak sales opportunity of $350 – $400 million. The acquisition talk with Collegium can also provide a boost to stock price

Strong Q3 numbers- Total Net Revenue of $41.1 Million, an Increase of 4% versus Prior Year, Strong profitability with GAAP EPS of $0.07, EBITDA Margin of 27% and $7.0 million Operating Cash Flow. Quick look at last 5 quarterly numbers

Increased Sales –Net sales of BELBUCA® and Symproic® combined grew 7.5% year-over-year. This growth was driven by record BELBUCA net sales of $36.9 million, which increased 6.3%, and Symproic net sales of $4.1 million, which increased 20%.

Improved EPS- last 3 Quarters out of 4, company has been reporting higher EPS than estimated, Q2 2021 EPS reported was 80% higher than estimated.

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedEarnings Per Share*Consensus EPS* Forecast% Surprise
Sep 202111/03/20210.070.0616.67
Jun 202108/04/20210.090.0580
Mar 202105/06/20210.050.07-28.57
Dec 202003/10/20210.10.0666.67

Quick Look at Company’s Key Data

In fiscal Year 2021 company shares have shown annual returns of around 30%. Last 1 Year Chart

Stock Recommendation: The company is on track for its second profitable year. Company is also set to launch a migraine treatment this quarter. Acquisition talk with Collegium & current market positivity in healthcare sector can also provide a boost to stock price

MarketFacts gives a “Buy” rating on the stock at the closing Price of $3.0 as of January 18th, 2022.

CMP (USD) (18th Jan 2022)$3.0
Target Price (CAD)$4.25
RecommendationBuy

Similar Posts

Diversify your portfolio by investing in this financial services company:PacWest Bancorp (NASDAQ:PACW)

Diversify your portfolio by investing in this financial services company:PacWest Bancorp (NASDAQ:PACW)

ByMarketFacts

PacWest Bancorp (NASDAQ:PACW) is a publicly-traded financial services holding company based in Beverly Hills, California. The company was founded in 1999. PacWest Bancorp operates as a bank holding company for its subsidiary, Pacific Western Bank, which provides commercial banking services to small and medium-sized businesses, as well as to individuals. The bank has a significant presence in California, with more than 60 branches across the state.

Why is this tough competitor in diversified services worth investing in: Aarons Holdings Company, Inc. (NYSE:AAN)?

Why is this tough competitor in diversified services worth investing in: Aarons Holdings Company, Inc. (NYSE:AAN)?

ByMarketFacts

Aarons Holdings Company, Inc. (NYSE: AAN) is a publicly traded holding company that owns and operates several subsidiaries in the retail and financial services industries. Its subsidiaries include Aaron’s, Inc., which is a lease-to-own retailer of furniture, electronics, and appliances, Progressive Leasing, which provides lease-purchase solutions for consumers who do not have established credit, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven. Aaron’s offers a direct-to-consumer lease-to-own solution through its approximately 1,300 Company-operated and franchised stores in 47 states and Canada, as well as on its e-commerce platform.

AST SpaceMobile, Inc. (NASDAQ: ASTS): Pioneering space-based cellular broadband network

AST SpaceMobile, Inc. (NASDAQ: ASTS): Pioneering space-based cellular broadband network

ByMarketFacts

AST SpaceMobile, Inc. (NASDAQ: ASTS), founded in 2017 by Abel Avellan and based in Midland, Texas, aims to create the first space-based cellular broadband network. This network will provide mobile broadband services directly to standard phones via low Earth orbit satellites, targeting remote and underserved areas. Their BlueWalker satellites, including the key BlueWalker 3 prototype, are designed to work with existing mobile phones, eliminating the need for specialized devices.

Shall you invest in this Renewable Solar Energy Company: Array Technologies Inc.(NASDAQ: ARRY)?
|

Shall you invest in this Renewable Solar Energy Company: Array Technologies Inc.(NASDAQ: ARRY)?

ByMarketFacts

Array Technologies Inc. (NASDAQ: ARRY) is a manufacturer of ground-mounting systems used in Solar Energy Projects. The company’s product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, and Rest of the World with the United States deriving most of the revenue.